Variant report
Variant | esv2429795 |
---|---|
Chromosome Location | chr5:177951313-177952909 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs557904212 | chr5:177951328-177951329 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs569802961 | chr5:177951343-177951344 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs537122397 | chr5:177951396-177951397 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs377515985 | chr5:177951437-177951438 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116316669 | chr5:177951516-177951517 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs558072194 | chr5:177951575-177951576 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs541328691 | chr5:177951576-177951577 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs552944088 | chr5:177951581-177951582 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577437103 | chr5:177951630-177951631 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs140297073 | chr5:177951654-177951655 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563125688 | chr5:177951681-177951682 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs531718203 | chr5:177951687-177951688 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs549329510 | chr5:177951700-177951701 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs562149750 | chr5:177951712-177951713 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs529229071 | chr5:177951736-177951737 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs632384 | chr5:177951781-177951782 | Weak transcription Genic enhancers Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs111590565 | chr5:177951797-177951798 | Weak transcription Genic enhancers Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs566346135 | chr5:177951841-177951842 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs376141348 | chr5:177951854-177951855 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533653950 | chr5:177951857-177951858 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75848518 | chr5:177951866-177951867 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs370202952 | chr5:177951876-177951877 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs150001568 | chr5:177951888-177951889 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs145255381 | chr5:177951901-177951902 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs28699028 | chr5:177951907-177951908 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs149134219 | chr5:177951909-177951910 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs567256070 | chr5:177951920-177951921 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs534294816 | chr5:177951939-177951940 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs553247173 | chr5:177952020-177952021 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs75202239 | chr5:177952021-177952022 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs180746870 | chr5:177952060-177952061 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs4355536 | chr5:177952071-177952072 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs575083469 | chr5:177952077-177952078 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs111601424 | chr5:177952111-177952112 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs111070775 | chr5:177952128-177952129 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs79505655 | chr5:177952131-177952132 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs4045503 | chr5:177952191-177952192 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs1694803 | chr5:177952251-177952252 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs112866504 | chr5:177952252-177952253 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs4994900 | chr5:177952311-177952312 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs66589613 | chr5:177952431-177952432 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371812238 | chr5:177952491-177952492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs375261436 | chr5:177952551-177952552 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs56371057 | chr5:177952591-177952592 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs1709750 | chr5:177952611-177952612 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs595320 | chr5:177952671-177952672 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs528464045 | chr5:177952711-177952712 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs543904284 | chr5:177952720-177952721 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs200937542 | chr5:177952729-177952730 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs67397648 | chr5:177952731-177952732 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 16751803 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Lung cancer | 18438408 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Prostate cancer | 18632612 | CNVD |
epilepsy | 18472482 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Sotos syndrome | 21572526 | CNVD |
T-cell acute lymphoblastic leukemia | 20065082 | CNVD |
Sotos syndrome | 17561922 | CNVD |
Sotos syndrome | 16773131 | CNVD |
Mental retardation | 16773131 | CNVD |
Sotos syndrome | 22470819 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Chordoma | 18071362 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
abnormal development | 18461090 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Lung cancer | 17297452 | CNVD |
Cancer | 20164920 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 21804112 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Sotos syndrome | 22283845 | CNVD |
Breast cancer | 16272173 | CNVD |
Sotos syndrome | 20503325 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Congenital Hypertrichosis Syndrome | 21636067 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 19181860 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ehlers-danlos syndrome | 17576883 | CNVD |
Lung cancer | 17086460 | CNVD |
Autism | 19246517 | CNVD |
Basal cell lymphoma | 19029149 | CNVD |
Diffuse large b-cell lymphoma | 19029149 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:177946600-177951400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr5:177947200-177953200 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
3 | chr5:177947800-177952800 | Weak transcription | ES-I3 Cell Line | embryonic stem cell |
4 | chr5:177948000-177952800 | Weak transcription | Cortex derived primary cultured neurospheres | brain |
5 | chr5:177950400-177953800 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
6 | chr5:177950800-177951400 | Enhancers | Dnd41 | blood |
7 | chr5:177951400-177951600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:177951400-177951600 | Weak transcription | Right Atrium | heart |
9 | chr5:177951600-177951800 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
10 | chr5:177951600-177951800 | Enhancers | Right Atrium | heart |
11 | chr5:177951800-177952800 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
12 | chr5:177951800-177953000 | Weak transcription | Right Atrium | heart |
13 | chr5:177952800-177953200 | Bivalent Enhancer | H1 Cell Line | embryonic stem cell |
14 | chr5:177952800-177953200 | Genic enhancers | Cortex derived primary cultured neurospheres | brain |
15 | chr5:177952800-177954000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
16 | chr5:177952800-177954400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
17 | chr5:177952800-177955200 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr5:177952800-177956400 | Enhancers | Left Ventricle | heart |